International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

Sunil-Dogra Headshot

Sunil

Dogra

,

MD, DNB, Dip. Dermatology, FRCP

Professor of Dermatology
Postgraduate Institute of Medical Education & Research
Chandigarh
,
India
Dr. Sunil Dogra is a Professor of Dermatology at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, a tertiary care referral centre in North India. Prof. Dogra has focused on clinical research in the disease characteristics and treatment of psoriasis with conventional systemic and oral small molecules and biological agents in resource-poor settings. He has participated in numerous national and international conferences, CMEs, and workshops. Professor Dogra has published over 450 peer-reviewed papers (more than 100 in Psoriasis) and authored and edited several textbooks on Dermatology, Leprosy, Paediatrics, Rheumatology, and Medicine, including the latest editions of Goldman-Cecil Medicine Textbook and Fitzpatrick’s Therapeutics: A Clinician’s Guide to Dermatologic Treatment. His highly cited publications include those in Lancet infectious Diseases, JAMA Dermatology, and Antimicrobial Agents & Chemotherapy. He has guided about 15 MD and two PhD theses over the last 20 years. In addition, he has participated in numerous clinical trials on psoriasis as principal investigator. In addition, he is an overseas member of several national dermatological associations, including EADV, ISD, AAD, and GRAPPA. He is an Editor Emeritus of the Indian Dermatology Online Journal and is on the Editorial Board of several Journals, including JAMA Dermatology and Clinical & Experimental Dermatology. He is the current (founder) President of the Hereditary Angioedema Society of India (HAESI) and past Vice President of the Indian Association of Leprologist. He is invited regularly as faculty at national/international conferences and has delivered more than 150 presentations. Prof. Dogra is a fellow of the Royal College of Physicians (London and Edinburgh).
Last Updated:
10/07/2022

Areas of Interest

Clinical, pediatric psoriasis, conventional systemic treatments, comorbidities, biologics, and apremilast.

Languages Spoken

English